Literature DB >> 30058055

Safety and efficacy of atrial fibrillation ablation guided by Ablation Index module.

Francesco Solimene1, Vincenzo Schillaci1, Gergana Shopova1, Francesco Urraro1, Alberto Arestia1, Assunta Iuliano2, Fabio Maresca2, Alessia Agresta2, Vincenzo La Rocca3, Antonio De Simone3, Giuseppe Stabile4.   

Abstract

PURPOSE: Reconnection of pulmonary veins (PVs) remains common following radiofrequency catheter ablation for atrial fibrillation (AF). Ablation Index (AI) is a novel ablation quality marker that incorporates stability, contact force (CF), time, and power in a weighted formula. Its use seems to improve lesion durability. This is a prospective, single-arm registry to investigate on the safety and mid-term efficacy of AF ablation guided by the AI.
METHODS: One hundred fifty-six consecutive patients (mean age 58 ± 10 years, 49% males, 44% with structural heart disease) referred for paroxysmal (124) or persistent (32) AF underwent antral PV isolation using a surround flow CF-sensing catheter guided by the AI. Radiofrequency was delivered targeting interlesion distance ≤ 6 mm and Ablation Index of 330-350 at posterior wall and 400-450 at anterior wall.
RESULTS: Mean overall procedure time was 95 ± 30 min with a mean fluoroscopy time of 5 ± 6 min. Mean ablation time was 26 ± 10 min, 627/628 targeted PV were isolated. One pericardial effusion and two groin hematomas were reported; none required intervention. During a mean follow-up of 14 ± 6 months, 17 (10.8%) (9% paroxysmal AF vs 22% persistent AF, p = 0.09) patients had an atrial arrhythmia recurrence.
CONCLUSIONS: PV ablation guided by AI resulted feasible, achieving a high rate of isolated PVs, with a low complication rate, and allowed a high single-procedure arrhythmia-free survival at 14 months.

Entities:  

Keywords:  Ablation Index; Atrial fibrillation; Catheter ablation; Contact force; Mid-term outcome; Safety

Mesh:

Year:  2018        PMID: 30058055     DOI: 10.1007/s10840-018-0420-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  14 in total

1.  Relationship Between Ablation Lesion Size Estimated by Ablation Index and Different Ablation Settings-an Ex Vivo Porcine Heart Study.

Authors:  Shu-Tao Huang; Jian-Zeng Dong; Xin Du; Jia-Hui Wu; Rong-Hui Yu; De-Yong Long; Man Ning; Cai-Hua Sang; Chen-Xi Jiang; Rong Bai; Song-Nan Wen; Nian Liu; Song-Nan Li; Wei Wang; Xue-Yuan Guo; Xin Zhao; Xuan Chen; Yi-Kai Cui; Ri-Bo Tang; Chang-Sheng Ma
Journal:  J Cardiovasc Transl Res       Date:  2020-06-02       Impact factor: 4.132

2.  An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience.

Authors:  Michela Casella; Antonio Dello Russo; Stefania Riva; Valentina Catto; Gabriele Negro; Rita Sicuso; Selene Cellucci; Alessio Gasperetti; Martina Zucchetti; Valentina Ribatti; Viviana Biagioli; Gaetano Fassini; Luigi Di Biase; Andrea Natale; Claudio Tondo
Journal:  J Interv Card Electrophysiol       Date:  2019-07-16       Impact factor: 1.900

3.  Pulmonary vein isolation using Ablation Index improves outcome in patients with atrial fibrillation.

Authors:  Jonas Elmer Pedersen; Kim Frost Lauritsen; Jens Brock Johansen; Niels Christian Foldager Sandgaard; Jorgen Dalhoj; Stig Djurhuus; Jacob Pontoppidan
Journal:  J Atr Fibrillation       Date:  2020-04-30

4.  The effect of left atrial wall thickness and pulmonary vein sizes on the acute procedural success of atrial fibrillation ablation.

Authors:  Melinda Boussoussou; Bálint Szilveszter; Borbála Vattay; Márton Kolossváry; Milán Vecsey-Nagy; Zoltán Salló; Gábor Orbán; Perge Péter; Piros Katalin; Nagy Klaudia Vivien; Osztheimer István; Pál Maurovich-Horvat; Béla Merkely; László Gellér; Nándor Szegedi
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-09       Impact factor: 2.357

5.  Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index: a multi-center, prospective randomized trial (PAF-AI trial).

Authors:  Ruhong Jiang; Minglong Chen; Jie Fan; Fu Yi; Anli Tang; Xingpeng Liu; Wenqing Zhu; Shaowen Liu; Xiaobo Huang; Weizhu Ju; Xi Zhang; Jie Li; Jiangui He; Liang Shi; Genqing Zhou; Yuegang Wang; Chenyang Jiang
Journal:  J Interv Card Electrophysiol       Date:  2020-05-11       Impact factor: 1.900

6.  How is Contact Force implemented in routine clinical practice? Results from a French National and Monaco Survey.

Authors:  Sok-Sithikun Bun; Decebal Gabriel Lațcu; Philippe Taghji; Frederic Anselme; Serge Boveda; Jean-Pierre Cebron; Pascal Defaye; Jean-Claude Deharo; Laurent Fauchier; Estelle Gandjbakhch; Daniel Gras; Didier Klug; Jacques Mansourati; Eloi Marijon; Jean-Philippe Maury; Fabien Squara; Nadir Saoudi; Jérôme Taïeb
Journal:  J Arrhythm       Date:  2019-02-15

7.  Relationship between the ablation index, lesion formation, and incidence of steam pops.

Authors:  Hitoshi Mori; Ritsushi Kato; Naokata Sumitomo; Yoshifumi Ikeda; Koji Goto; Sayaka Tanaka; So Asano; Mai Tahara; Takahiko Nagase; Shiro Iwanaga; Toshihiro Muramatsu; Kazuo Matsumoto
Journal:  J Arrhythm       Date:  2019-06-01

8.  Impact of cavotricuspid isthmus depth on the ablation index for successful first-pass typical atrial flutter ablation.

Authors:  Manabu Kashiwagi; Akio Kuroi; Yosuke Katayama; Kosei Terada; Suwako Fujita; Takeshi Hozumi; Kunihiro Shimamura; Yasutsugu Shiono; Takashi Tanimoto; Takashi Kubo; Atsushi Tanaka; Takashi Akasaka
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

Review 9.  Late arrhythmia recurrence after atrial fibrillation ablation: incidence, mechanisms and clinical implications.

Authors:  Nico Erhard; Andreas Metzner; Thomas Fink
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-01-10

10.  Characterizing clinical outcomes and factors associated with conduction gaps in VISITAG SURPOINT-guided catheter ablation for atrial fibrillation.

Authors:  Koichi Inoue; Nobuaki Tanaka; Yusuke Ikada; Akihiro Mizutani; Kazuhiko Yamamoto; Hana Matsuhira; Shinichi Harada; Masato Okada; Katsuomi Iwakura; Kenshi Fujii
Journal:  J Arrhythm       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.